1-2 of 2
Andrew Doyle, MBBS, BSc, FRPATH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Direct Oral Anticoagulants for Myeloproliferative Neoplasms (MPN-DOACs): Results from an International Study on 442 Patients

Tiziano Barbui, MD, Valerio De Stefano, MD, Alessandra Carobbio, BSc, Alessandra Iurlo, MD PhD, Alberto Alvarez-Larran, MD, Alessandro M. Vannucchi, MD, Francesca Palandri, MD PhD, Claire Harrison, DM, FRCP, FRCPath, Hassan Sibai, MBBS, Martin Griesshammer, MD PhD, Massimiliano Bonifacio, MD, Elena M Elli, MD, Chiara Trotti, MD, Steffen Koschmieder, MD, Giuseppe Carli, MD, Giulia Benevolo, Jean-Christophe Ianotto, MD PhD, Swati Goel, MD, Anna Falanga, MD, Silvia Betti, MD PhD, Daniele Cattaneo, MD, Eduardo Arellano-Rodrigo, MD, Lara Mannelli, MD, Nicola Vianelli, MD, Andrew Doyle, MBBS, BSc, FRPATH, Vikas Gupta, MD FRCP, FRCPath, Kai Wille, MD, Douglas Tremblay, MD, John Mascarenhas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-139229
Published: 2020
Journal Articles

Outcomes of Patients Receiving Direct Oral Anticoagulants for Myeloproliferative Neoplasm Associated Venous Thromboembolism

Andrew Doyle, MBBS, BSc, FRPATH, Karen Breen, MD, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, Deepti Radia, Beverley J. Hunt, Gavin Ling, MBBS, BSc, FRCPath, Claire N Harrison, Professor, Natalia Curto Garcia, MD MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4183.
https://doi.org/10.1182/blood-2019-128170
Published: 2019